SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $192,000 | -28.9% | 12,800 | -58.3% | 0.03% | -15.4% |
| Q2 2017 | $270,000 | +280.3% | 30,700 | +124.1% | 0.04% | +1850.0% |
| Q1 2017 | $71,000 | -10.1% | 13,700 | -19.4% | 0.00% | -90.9% |
| Q3 2016 | $79,000 | -9.2% | 17,000 | +12.6% | 0.02% | -81.8% |
| Q2 2016 | $87,000 | -63.0% | 15,100 | -61.2% | 0.12% | +19.8% |
| Q1 2016 | $235,000 | -67.4% | 38,900 | -15.3% | 0.10% | -32.2% |
| Q1 2015 | $720,000 | +27.4% | 45,900 | +24.1% | 0.15% | -43.6% |
| Q2 2014 | $565,000 | – | 37,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |